Pony.ai Advances Global Deployment with Launch of Europe's First Commercial Robotaxi Service in Zagreb

Pony.ai Advances Global Deployment with Launch of Europe's First Commercial Robotaxi Service in Zagreb

Members of the public can now book rides through the Verne app in Zagreb, Croatia, with Uber app integration to follow The launch marks a new milestone in Pony.ai's dual-engine growth strategy ZAGREB, Croatia, April 8, 2026 /PRNewswire/ -- Pony AI...

Argon & Co Advances AI-Enabled Business Transformation Model, Promotes Four New Partners

Argon & Co Advances AI-Enabled Business Transformation Model, Promotes Four New Partners

SYDNEY, April 8, 2026 /PRNewswire/ -- Argon & Co, the global management consultancy specialising in operations strategy and transformation, is evolving its delivery model to embed data, digital capability and AI into end-to-end transformation,...

UTP Advances Across Key Disciplines in QS World University Rankings By Subject 2026 - Petroleum Engineering Among World's Top 10

UTP Advances Across Key Disciplines in QS World University Rankings By Subject 2026 - Petroleum Engineering Among World's Top 10

SERI ISKANDAR, Malaysia, April 6, 2026 /PRNewswire/ -- Universiti Teknologi PETRONAS (UTP) has achieved a significant milestone in the QS World University Rankings by Subject 2026, with its Petroleum Engineering discipline rising to 9th globally,...

PQShield Advances Japan's Quantum-Safe Security Transition Through CRYPTREC ML-KEM Evaluation

PQShield Advances Japan's Quantum-Safe Security Transition Through CRYPTREC ML-KEM Evaluation

Japan can now begin deploying quantum-safe encryption at scale following PQShield's evaluation of ML-KEM, as standardised in NIST FIPS 203, for CRYPTREC The milestone unlocks adoption across Japan's government procurement and technology supply...

Massimo Group Reports FY2025 Results, Delivers Margin Expansion and Advances Premium Product Pipeline

Massimo Group Reports FY2025 Results, Delivers Margin Expansion and Advances Premium Product Pipeline

Company Highlights Improved Gross Margins, Strengthened Dealer Channel and Expands Premium HVAC Product Offerings GARLAND, Texas, April 1, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company") today announced its financial...

Mesabi Metallics Secures $520 Million from Breakwall Capital - Advances towards Q3 2026 start of New American Iron Ore Mine

Mesabi Metallics Secures $520 Million from Breakwall Capital - Advances towards Q3 2026 start of New American Iron Ore Mine

Financing supports U.S. critical mineral security and helps reshore the American steel supply chain NASHWAUK, Minn., April 1, 2026 /PRNewswire/ -- Mesabi Metallics Company LLC (Mesabi Metallics), backed by the Essar Group, today announced that it...

Hisense Advances a Quiet Green Revolution in Home Entertainment

Hisense Advances a Quiet Green Revolution in Home Entertainment

QINGDAO, China, March 28, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, is advancing energy-efficient innovation across the industry as sustainability becomes an increasingly important part of...

HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering

HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering

Listing milestone positions HanchorBio to strengthen institutional visibility, advance its FBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases TAIPEI, SHANGHAI and SAN FRANCISCO, March 25, 2026...

VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial

VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial

Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment Fully biological...

Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab

Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab

HONG KONG, March 25, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • menu
    menu